Chicken Polyclonal Ki67 antibody. Suitable for ICC, WB and reacts with Human samples. Cited in 9 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human MKI67.
View Alternative Names
Proliferation marker protein Ki-67, Antigen identified by monoclonal antibody Ki-67, Antigen KI-67, Antigen Ki67, MKI67
- ICC
Supplier Data
Immunocytochemistry - Anti-Ki67 antibody (AB254123)
HeLa (human epithelial cell line from cervix adenocarcinoma) cells stained for Ki67 (red) using ab254123 at 1/1000 dilution in ICC. Beta tubulin is stained (green). Nuclei are shown in blue.
- WB
Supplier Data
Western blot - Anti-Ki67 antibody (AB254123)
All lanes:
Western blot - Anti-Ki67 antibody (ab254123) at 1/5000 dilution
All lanes:
T-47D (human ductal breast epithelial tumor cell line) (serum starved / re-fed for 2.5 hours) cell lysate
Predicted band size: 358 kDa
false
Reactivity data
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The Ki67 protein plays an essential role in cellular proliferation processes. It does not form part of a stable complex but interacts transiently with other cell cycle-related proteins. Research indicates that Ki67 maintains the structure of the perichromosomal layer during mitosis impacting chromosome separation. It is particularly active in tissues with high cell turnover such as bone marrow and lymphoid organs.
Pathways
Ki67 influences several key cellular pathways that control cell proliferation and differentiation. The protein acts within the regulation of the cell cycle and the PI3K/AKT signaling pathway important for cell growth and survival. Within these pathways Ki67 interacts with proteins like cyclin-dependent kinases (CDKs) which regulate transitions between different phases of the cell cycle.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 15:9529 PubMed39532843
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 14:264 PubMed37041150
2023
Applications
Unspecified application
Species
Unspecified reactive species
Thoracic cancer 14:881-892 PubMed36811283
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed36768530
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 12:906194 PubMed36147919
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:2194-2206 PubMed35030977
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 22:773 PubMed34589152
2021
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 8:e2004846 PubMed34060252
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 43:1805-1818 PubMed32236603
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com